Literature DB >> 4847538

Inhibition of mammalian brain acetylcholinesterase by ketamine.

M G Cohen, S L Chan, H N Bhargava, A J Trevor.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4847538     DOI: 10.1016/0006-2952(74)90377-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

Review 1.  Ketamine for treatment-resistant unipolar depression: current evidence.

Authors:  Sanjay J Mathew; Asim Shah; Kyle Lapidus; Crystal Clark; Noor Jarun; Britta Ostermeyer; James W Murrough
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

2.  Effect of pentobarbital on the synaptosomal activity of acetylcholinesterase in Mongolian gerbils.

Authors:  D Micic; J Micic; I Kaltzo; M Spatz
Journal:  Experientia       Date:  1978-02-15

3.  The impact of NMDA receptor blockade on human working memory-related prefrontal function and connectivity.

Authors:  Naomi R Driesen; Gregory McCarthy; Zubin Bhagwagar; Michael H Bloch; Vincent D Calhoun; Deepak C D'Souza; Ralitza Gueorguieva; George He; Hoi-Chung Leung; Ramachandran Ramani; Alan Anticevic; Raymond F Suckow; Peter T Morgan; John H Krystal
Journal:  Neuropsychopharmacology       Date:  2013-07-16       Impact factor: 7.853

4.  Ketamine induces dopamine-dependent depression of evoked hippocampal activity in the nucleus accumbens in freely moving rats.

Authors:  Mark J Hunt; Karima Kessal; Rene Garcia
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

5.  Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans.

Authors:  N R Driesen; G McCarthy; Z Bhagwagar; M Bloch; V Calhoun; D C D'Souza; R Gueorguieva; G He; R Ramachandran; R F Suckow; A Anticevic; P T Morgan; J H Krystal
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992

6.  The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use.

Authors:  Sarbjeet S Kalsi; David M Wood; Paul I Dargan
Journal:  Emerg Health Threats J       Date:  2011-04-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.